DHFR and neoplasm: An explanation for this finding was the downregulation of most enzymes of the OCM by simvastatin, as shown in Figure 3, in three tumor cell lines that may act additionally to the inhibition of the DHFR by methotrexate (Table 4), however, it is not clear which of these pathways is responsible for the antiproliferative effect of statins.